Banle Logo_20x20cm_EngOnly.jpg
萬利集團在「投資者網路研討會」分享可持續發展的商業策略
April 25, 2024 00:51 ET | CBL International Limited
香港, April 25, 2024 (GLOBE NEWSWIRE) -- 萬利集團(以下簡稱「集團」)(美國納斯達克交易所代碼:BANL),亞太地區領先的船舶燃油供應公司,於2024年4月23日舉辦「投資者網路研討會」。...
Banle Logo_20x20cm_EngOnly.jpg
万利集团在「投资者网络研讨会」分享可持续发展的商业策略
April 25, 2024 00:51 ET | CBL International Limited
香港, April 25, 2024 (GLOBE NEWSWIRE) --...
Banle Logo_20x20cm_EngOnly.jpg
Banle Group Highlights Strategies for Sustainable Growth During Investor Webinar
April 25, 2024 00:51 ET | CBL International Limited
Banle Group Highlights Strategies for Sustainable Growth During Investor Webinar
Marex Group.png
Marex Group plc Announces Pricing of Initial Public Offering
April 24, 2024 21:33 ET | Marex Group plc
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at...
Futu Holdings Limited Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2023
April 24, 2024 20:12 ET | Futu Holdings Limited
HONG KONG, April 25, 2024 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced...
MethanexLogo.jpg
Methanex Corporation – Notice of Cash Dividend
April 24, 2024 19:59 ET | Methanex Corporation
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Methanex Corporation (the “Company” or “Methanex”) (TSX:MX) (NASDAQ:MEOH) announced today that its Board of Directors has declared a...
Merus logo.jpg
Merus gibt Annahme von Abstracts zur Präsentation auf der ASCO-Jahrestagung 2024 bekannt
April 24, 2024 19:54 ET | Merus N.V.
Petosemtamab in Kombination mit Pembrolizumab als 1L bei HNSCC – erste vorläufige klinische Daten für eine mündliche Kurzpräsentation ausgewählt MCLA-145 als Monotherapie oder in Kombination mit...
Merus logo.jpg
Merus annonce les résumés acceptés pour présentation à la réunion annuelle 2024 de l’ASCO
April 24, 2024 19:54 ET | Merus N.V.
Pétosemtamab en association avec le pembrolizumab en traitement de première intention du carcinome épidermoïde de la tête et du cou : premières données cliniques provisoires sélectionnées pour une...
Hanryu Holdings, Inc. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
April 24, 2024 19:40 ET | Hanryu Holdings, Inc.
Seoul, Republic of South Korea, April 24, 2024 (GLOBE NEWSWIRE) -- Hanryu Holdings, Inc. (NASDAQ: HRYU) (“Hanryu” or the “Company”), a media-tech company and creator of FANTOO, an all-in-one social...
new logo.jpg
Northfield Bancorp, Inc. Announces First Quarter 2024 Results
April 24, 2024 19:18 ET | Northfield Bancorp, Inc.
NOTABLE ITEMS FOR THE QUARTER INCLUDE: DILUTED EARNINGS PER SHARE WERE $0.15 FOR THE CURRENT QUARTER COMPARED TO $0.19 FOR THE TRAILING QUARTER, AND $0.26 FOR THE FIRST QUARTER OF 2023.NET INTEREST...